Primary biliary cirrhosis pathophysiology: Difference between revisions
Line 44: | Line 44: | ||
===Pathogenesis=== | ===Pathogenesis=== | ||
*The exact pathogenesis of primary biliary cirrhosis is not fully understood. | *The exact pathogenesis of primary biliary cirrhosis is not fully understood. | ||
*It is thought that primary biliary cirrhosis is the result of antimitochondrial antibodies (AMAs), directed to the E2 component of the pyruvate dehydrogenase complex (PDC-E2). | *It is thought that primary biliary cirrhosis is the result of antimitochondrial antibodies (AMAs), directed to the E2 component of the pyruvate dehydrogenase complex (PDC-E2).<ref name="pmid15122771">{{cite journal| author=Matsumura S, Van De Water J, Leung P, Odin JA, Yamamoto K, Gores GJ et al.| title=Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. | journal=Hepatology | year= 2004 | volume= 39 | issue= 5 | pages= 1415-22 | pmid=15122771 | doi=10.1002/hep.20175 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15122771 }} </ref> | ||
<br> | <br> | ||
<div style="text-align: center;">'''Algorithm showing postulated hypothesis of pathogenesis of primary biliary cirrhosis'''<ref name="pmid19185000">{{cite journal| author=Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR et al.| title=Apotopes and the biliary specificity of primary biliary cirrhosis. | journal=Hepatology | year= 2009 | volume= 49 | issue= 3 | pages= 871-9 | pmid=19185000 | doi=10.1002/hep.22736 | pmc=2665925 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19185000 }} </ref></div> | <div style="text-align: center;">'''Algorithm showing postulated hypothesis of pathogenesis of primary biliary cirrhosis'''<ref name="pmid19185000">{{cite journal| author=Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR et al.| title=Apotopes and the biliary specificity of primary biliary cirrhosis. | journal=Hepatology | year= 2009 | volume= 49 | issue= 3 | pages= 871-9 | pmid=19185000 | doi=10.1002/hep.22736 | pmc=2665925 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19185000 }} </ref><ref name="pmid11457875">{{cite journal| author=Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A| title=Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. | journal=J Clin Invest | year= 2001 | volume= 108 | issue= 2 | pages= 223-32 | pmid=11457875 | doi=10.1172/JCI10716 | pmc=203018 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11457875 }} </ref><ref name="pmid8129031">{{cite journal| author=Charlotte F, L'Herminé A, Martin N, Geleyn Y, Nollet M, Gaulard P et al.| title=Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. | journal=Am J Pathol | year= 1994 | volume= 144 | issue= 3 | pages= 460-5 | pmid=8129031 | doi= | pmc=1887102 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8129031 }} </ref><ref name="pmid18181218">{{cite journal| author=Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A et al.| title=Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. | journal=Hepatology | year= 2008 | volume= 47 | issue= 3 | pages= 958-65 | pmid=18181218 | doi=10.1002/hep.22102 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18181218 }} </ref></div> | ||
<br> | <br> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 58: | Line 58: | ||
{{Family tree | | | | | | | | | | | | D01 | | | | | | | | | | | D01=Prevents loss of immunogenicity after apoptpsis of BEC}} | {{Family tree | | | | | | | | | | | | D01 | | | | | | | | | | | D01=Prevents loss of immunogenicity after apoptpsis of BEC}} | ||
{{Family tree | | | | | | | | | | | | |!| | | | | | | | | | | | }} | {{Family tree | | | | | | | | | | | | |!| | | | | | | | | | | | }} | ||
{{Family tree | | | | | | | | | | | | E01 | | | | | | | | | | | E01=PDC-E2 remains intact and antigenic in apoptotic blebs of BEC}} | {{Family tree | | | | | | | | | | | | E01 | | | | | | | | | | | E01=PDC-E2 component remains intact and antigenic in apoptotic blebs of BEC}} | ||
{{Family tree | | | | | | | | | | | | |!| | | | | | | | | | | | }} | {{Family tree | | | | | | | | | | | | |!| | | | | | | | | | | | }} | ||
{{Family tree | | | | | | | | | | | | F01 | | | | | | | | | | | F01=Antigenic PDC-E2 are engulfed by intrahepaticc dendritic cells}} | {{Family tree | | | | | | | | | | | | F01 | | | | | | | | | | | F01=Antigenic PDC-E2 are engulfed by intrahepaticc dendritic cells}} |
Revision as of 16:12, 6 February 2018
Primary Biliary Cirrhosis Microchapters |
Differentiating Primary Biliary Cirrhosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary biliary cirrhosis pathophysiology On the Web |
American Roentgen Ray Society Images of Primary biliary cirrhosis pathophysiology |
Risk calculators and risk factors for Primary biliary cirrhosis pathophysiology |
https://https://www.youtube.com/watch?v=CQtHOMzLzwU%7C350}} |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Pathogenesis
- The exact pathogenesis of primary biliary cirrhosis is not fully understood.
- It is thought that primary biliary cirrhosis is the result of antimitochondrial antibodies (AMAs), directed to the E2 component of the pyruvate dehydrogenase complex (PDC-E2).[1]
Biliary epithelial cells (BEC) | |||||||||||||||||||||||||||||||||||||||||||||||||
Overexpression of Bcl-2 in small apoptotic BEC | Cell lineage specific lack of glutathione | ||||||||||||||||||||||||||||||||||||||||||||||||
Inhibition of PDC-E2 glutathiolation | |||||||||||||||||||||||||||||||||||||||||||||||||
Prevents loss of immunogenicity after apoptpsis of BEC | |||||||||||||||||||||||||||||||||||||||||||||||||
PDC-E2 component remains intact and antigenic in apoptotic blebs of BEC | |||||||||||||||||||||||||||||||||||||||||||||||||
Antigenic PDC-E2 are engulfed by intrahepaticc dendritic cells | |||||||||||||||||||||||||||||||||||||||||||||||||
Dendritic cells transfer antigenic PDC-E2 to regional lymph nodes | |||||||||||||||||||||||||||||||||||||||||||||||||
Antigenic PDC-E2 is recognized by MHC class I restricted CD8+ T cells | |||||||||||||||||||||||||||||||||||||||||||||||||
Initiates autoimmunity | |||||||||||||||||||||||||||||||||||||||||||||||||
Primary biliary cirrhosis | |||||||||||||||||||||||||||||||||||||||||||||||||
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Conditions associated with primary biliary cirrhosis include:[6][7]
- Addison's disease
- Autoimmune thrombocytopenic purpura
- Celiac disease
- CREST syndrome
- Crohn's disease
- Dermatomyositis
- Diabetes mellitus type 1
- Gallstones
- Glomerulonephritis
- Grave's disease
- Hashimoto's thyroiditis
- Lichen planus
- Mixed connective tissue disorder
- Myasthenia gravis
- Pemphigoid
- Pernicious anemia
- Polymyositis
- Psoriasis
- Pulmonary fibrosis
- Raynaud's disease
- Rheumatoid arthritis
- Sarcoidosis
- Scleroderma
- Sjogren's syndrome
- Systemic lupus erythematosus
- Ulcerative colitis
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
- On microscopic histopathological analysis, asymmetric destruction of the intralobular bile ducts within portal triads is characteristic findings of primary biliary cirrhosis.
Histopathology
References
- ↑ Matsumura S, Van De Water J, Leung P, Odin JA, Yamamoto K, Gores GJ; et al. (2004). "Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis". Hepatology. 39 (5): 1415–22. doi:10.1002/hep.20175. PMID 15122771.
- ↑ Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR; et al. (2009). "Apotopes and the biliary specificity of primary biliary cirrhosis". Hepatology. 49 (3): 871–9. doi:10.1002/hep.22736. PMC 2665925. PMID 19185000.
- ↑ Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A (2001). "Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis". J Clin Invest. 108 (2): 223–32. doi:10.1172/JCI10716. PMC 203018. PMID 11457875.
- ↑ Charlotte F, L'Herminé A, Martin N, Geleyn Y, Nollet M, Gaulard P; et al. (1994). "Immunohistochemical detection of bcl-2 protein in normal and pathological human liver". Am J Pathol. 144 (3): 460–5. PMC 1887102. PMID 8129031.
- ↑ Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A; et al. (2008). "Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells". Hepatology. 47 (3): 958–65. doi:10.1002/hep.22102. PMID 18181218.
- ↑ Kumagi T, Heathcote EJ (2008). "Primary biliary cirrhosis". Orphanet J Rare Dis. 3: 1. doi:10.1186/1750-1172-3-1. PMC 2266722. PMID 18215315.
- ↑ Watt FE, James OF, Jones DE (2004). "Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study". QJM. 97 (7): 397–406. PMID 15208427.